US 8222215
Methods for the use of inhibitors of antigen presentation by MHC class II molecules
granted A61KA61K38/00A61P
Quick answer
US patent 8222215 (Methods for the use of inhibitors of antigen presentation by MHC class II molecules) held by Provid Pharmaceuticals Inc. expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Provid Pharmaceuticals Inc.
- Grant date
- Tue Jul 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/00, A61P, A61P19/02, A61P25/00